Trexquant Investment’s Solid Biosciences SLDB Stock Holding History

Trexquant Investment’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$691K	Sell	69,128 -54,778	-44%	-$415K	﹤0.01%	1564
2026 Q1	$892K	Buy	+123,906	New	+$796K	0.01%	1268
2025 Q4	–	Sell	-70,448	Closed	-$435K	–	1897
2025 Q3	$435K	Buy	+70,448	New	+$412K	﹤0.01%	1347
2025 Q2	–	Sell	-167,031	Closed	-$618K	–	1844
2025 Q1	$618K	Sell	167,031 -27,250	-14%	-$117K	0.01%	1227
2024 Q4	$777K	Buy	194,281 +139,851	+257%	+$768K	0.01%	1179
2024 Q3	$379K	Buy	54,430 +9,267	+21%	+$75.2K	﹤0.01%	1304
2024 Q2	$256K	Buy	+45,163	New	+$404K	﹤0.01%	1398
2019 Q3	–	Sell	-1,605	Closed	-$138K	–	1094
2019 Q2	$138K	Buy	1,605 +663	+70%	+$72.3K	0.01%	723
2019 Q1	$130K	Buy	+942	New	+$236K	0.01%	914
2018 Q4	–	Sell	-482	Closed	-$341K	–	1280
2018 Q3	$341K	Buy	+482	New	+$303K	0.03%	652

Other funds holding SLDB

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Trexquant Investment's SLDB Position: Q2 2026 in Review

Trexquant Investment reduced its Solid Biosciences (SLDB) stake by 44% in Q2 2026, selling an estimated $415K and leaving 69,128 shares worth $691K. The position accounts for ﹤0.01% of the portfolio, ranked #1564.

Trexquant Investment first reported a position in SLDB in Q3 2018 and has held it in 10 quarters since. The position peaked at $892K in Q1 2026. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

Trexquant Investment held 69,128 shares of Solid Biosciences worth $691K as of Q2 2026.
Trexquant Investment sold 54,778 Solid Biosciences shares in Q2 2026, an estimated $415K.
Solid Biosciences made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1564 holding.
Trexquant Investment first reported a position in Solid Biosciences in Q3 2018 and has held it in 10 quarters since.
Trexquant Investment's Solid Biosciences position peaked at $892K in Q1 2026.
157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.